Text Size

Cost Effectiveness and Utility of Computed Tomography Angiography (CTA) and Cardiac Cath

This study is currently recruiting participants.
Verified August 2011 by University of Michigan
Sponsor:
Information provided by:
University of Michigan
ClinicalTrials.gov Identifier:
NCT00722813
First received: July 24, 2008
Last updated: August 29, 2011
Last verified: August 2011
History of Changes
  Purpose

This is a research study to determine patient preferences between two different diagnostic tests; a CT angiogram (CTA) and a catheter angiogram, both of which are used at the University to screen for and detect heart disease.


Condition Intervention
Heart Diseases
 Other: Survey

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Cost Effectiveness and Utility of Coronary Artery Computed Tomography Angiography (CTA) in Screening for Coronary Artery Disease

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Michigan:

Estimated Enrollment: 100
Study Start Date: October 2006
Intervention Details:
    Other: Survey
    To determine patient preference for the two tests CT angiography (CTA) and catheter coronary angiography (CCA).
Detailed Description:

This is a single site study that will retrospectively and prospectively identify and enroll 100 subjects, both male and female, 18 years of age and older who undergo both coronary angiography and coronary artery computed tomography (CT), using the electronic radiology and cardiology databases. The purpose is to conduct a survey to assess their preference for either test to diagnose coronary artery disease. Subjects should be within six months of having the tests to avoid memory and recall problems.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Subjects who have had both CTA and Cardiac catherizations

Criteria

Inclusion Criteria:

  • Subjects who have had both CTA and Coronary angiogram.
  • 18 years old and older.

Exclusion Criteria:

  • Under 18 years of age

  • Memory Impairment:

    • Stroke
    • Traumatic brain Injury
    • Dementia
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00722813

Contacts
Contact: Aine Kelly, MD 734-936-0024 ainekell@med.umich.edu

Locations
United States, Michigan
University of Michigan Health Systems Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Aine Kelly     734-936-0024        
Principal Investigator: Aine Kelly, MD            
Sponsors and Collaborators
University of Michigan
Investigators
Principal Investigator: Aine Kelly, MD University of Michigan Health System
  More Information

No publications provided

Responsible Party: Dr. Aine Kelly, University of Michigan
ClinicalTrials.gov Identifier: NCT00722813     History of Changes
Other Study ID Numbers: HUM00003409
Study First Received: July 24, 2008
Last Updated: August 29, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Coronary Artery Disease
Heart Diseases
Coronary Disease
Myocardial Ischemia
 Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 21, 2013